The physiological rationale for oral insulin administration
- PMID: 15321008
- DOI: 10.1089/1520915041705929
The physiological rationale for oral insulin administration
Abstract
Insulin remains the most effective and durable drug in the armamentarium for the treatment of advanced-stage diabetes. Nevertheless, clinical studies have shown that even on insulin treatment, a significant percentage of patients fail to attain lasting glycemic control. Well-recognized reasons for this failure include issues related to patients' noncompliance with an injectable drug and the late stage at which insulin is prescribed, but less explicit reasons related to the nonphysiological way insulin is currently administered are equally important. Parenteral insulin targets peripheral tissue rather than the liver with pharmacokinetics that do not replicate the normal dynamics of endogenous insulin release. Oral insulin is one of several alternative methods of insulin administration that are in clinical stages of development. The oral route of insulin delivery takes advantage of the portal-hepatic route of absorption. A review of relevant physiology is herewith provided.
Similar articles
-
Oral insulin: the rationale for this approach and current developments.J Diabetes Sci Technol. 2009 May 1;3(3):562-7. doi: 10.1177/193229680900300322. J Diabetes Sci Technol. 2009. PMID: 20144296 Free PMC article. Review.
-
Nanoparticle strategies for the oral delivery of insulin.Expert Opin Drug Deliv. 2008 Jan;5(1):45-68. doi: 10.1517/17425247.5.1.45. Expert Opin Drug Deliv. 2008. PMID: 18095928 Review.
-
[Inhaled insulin, new perspective for insulin therapy].Rev Med Liege. 2005 May-Jun;60(5-6):355-60. Rev Med Liege. 2005. PMID: 16035294 Review. French.
-
[Biotechnological and administration innovations in insulin therapy].Med Sci (Paris). 2004 Nov;20(11):986-98. doi: 10.1051/medsci/20042011986. Med Sci (Paris). 2004. PMID: 15525494 Review. French.
-
Clinical evaluation of inhaled insulin.Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):1061-75. doi: 10.1016/j.addr.2006.07.019. Epub 2006 Aug 17. Adv Drug Deliv Rev. 2006. PMID: 17070613 Review.
Cited by
-
pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.Drug Deliv. 2017 Nov;24(1):569-581. doi: 10.1080/10717544.2017.1279238. Drug Deliv. 2017. PMID: 28195032 Free PMC article. Review.
-
Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin.AAPS PharmSciTech. 2011 Sep;12(3):958-64. doi: 10.1208/s12249-011-9647-5. Epub 2011 Jul 15. AAPS PharmSciTech. 2011. PMID: 21761276 Free PMC article.
-
Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews.Cochrane Database Syst Rev. 2018 Aug 14;8(8):CD012327. doi: 10.1002/14651858.CD012327.pub2. Cochrane Database Syst Rev. 2018. PMID: 30103263 Free PMC article.
-
Multifunctional Composite Microcapsules for Oral Delivery of Insulin.Int J Mol Sci. 2016 Dec 28;18(1):54. doi: 10.3390/ijms18010054. Int J Mol Sci. 2016. PMID: 28036045 Free PMC article.
-
pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin.Int J Nanomedicine. 2015 May 11;10:3489-98. doi: 10.2147/IJN.S81715. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25999713 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical